RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 49.0457

Change

-1.00 (-2.01)%

Market Cap

N/A

Volume

8.17K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.58 (-3.22%)

USD 8.29B
QLD ProShares Ultra QQQ

-0.66 (-0.73%)

USD 8.27B
SSO ProShares Ultra S&P500

-1.38 (-1.66%)

USD 5.76B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 5.57B
UPRO ProShares UltraPro S&P500

-1.88 (-2.51%)

USD 4.34B
TECL Direxion Daily Technology Bull..

-0.86 (-1.39%)

USD 2.48B
YINN Direxion Daily FTSE China Bull..

+1.67 (+3.91%)

USD 1.91B
USD ProShares Ultra Semiconductors

+0.80 (+1.91%)

USD 1.16B
UDOW ProShares UltraPro Dow30

-3.13 (-3.54%)

USD 0.77B
LABU Direxion Daily S&P Biotech Bul..

-0.40 (-0.53%)

USD 0.77B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.14 (+0%)

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.24 (0%)

USD 8.75B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.23B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

-0.53 (0%)

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.50% 79% B- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.50% 79% B- 92% A
Trailing 12 Months  
Capital Gain -6.56% 46% F 27% F
Dividend Return 1.47% 69% C- 27% F
Total Return -5.08% 46% F 25% F
Trailing 5 Years  
Capital Gain 131.40% 66% D+ 81% B-
Dividend Return 6.14% 60% D- 12% F
Total Return 137.54% 64% D 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.79% 25% F 66% D+
Dividend Return 11.14% 25% F 62% D
Total Return 0.35% 23% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.28% 97% N/A 33% F
Risk Adjusted Return 35.62% 57% F 49% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.